Study characteristics | |||
Patient sampling | Prospective study | ||
Patient characteristics and setting | Sample size: 64 patients Mean age: 57.4 years (+/‐ 12,7) Presentation: Patients undergoing surgery for a suspected advanced ovarian or peritoneal cancer, exclusion advanced ASA or very large mass reaching xiphoid/occupying the abdominal wall or cavity. Included also if on radiologic and clinical criteria suspected of unresectable disease. Diagnostics before index test: physical/gynaecological examination, ultrasonography, CA 125, CT abdomen/pelvis, Thorax x‐ray/CT Kind of surgery: All patients received explorative laparotomy. Performed before: PDS 42; IDS 19: recurrence: 3 |
||
Index tests | Open diagnostic laparoscopy, investigating frozen pelvis, omental cake, diaphragmatic or peritoneal extensive carcinomatosis, tumour diffusion to the large and small curvature of the stomach, large and/or small bowel mesentery disease, spleen and/or liver metastases, bulky lymph nodes. Cut‐off test‐positivity: absence of criteria for un resectability Complications of index test: none |
||
Target condition and reference standard(s) | Target condition: resectability of tumour residual of less than 1 cm not possible Criteria for target condition: extensive peritoneal carcinomatosis/involvement of bowel mesentery/bulky disease diaphragm/ portal triad disease/unresectable upper abdominal metastasis Reference standard: Explorative laparotomy. Test operators: not reported percentage of patients Reference stand performed: 100% Unresectable disease at laparotomy: 23 |
||
Flow and timing | Time between reference standard and index test: 0 day. | ||
Comparative | |||
Notes | Not only patients planned for primary surgery, but also planned for IDS or secondary surgery because of recurrence. After inclusion and laparotomy FIGO I‐II, III‐IV 9‐42 respectivily, 6 benign, 7 other tumour | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Yes | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Were the patients suspected of advanced ovarian cancer by conventional diagnostic work‐up? | Yes | ||
Were patients planned for primary cytoreductive surgery after conventional diagnostic work‐up? | No | ||
High | |||
DOMAIN 2: Index Test Diagnostic open laparoscopy | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Were the same clinical data available when test results were interpreted as would be available when the test is used in practice? | Yes | ||
Did the study provide a clear definition of what was considered to be a "positive "result for the index test? | Yes | ||
Low | |||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | No | ||
Low | |||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Were all patients included in the analysis? | No | ||
Did patients receive the same reference standard regardless of the index test result? | Yes | ||